Long-term clinical impact of vascular brain lesions on magnetic resonance imaging in older adults in the population

Stroke

Volumn 47, Issue 11, 2016, Pages 2865-2869

  Kaffashian, Sara ^a   Soumaré, Aïcha ^a   Zhu, Yi Cheng ^b   Mazoyer, Bernard ^a   Debette, Stéphanie ^a,c,d   Tzourio, Christophe ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cerebral small vessel disease; dementia; epidemiology; magnetic resonance imaging; stroke

Indexed keywords

AGED; ARTICLE; BRAIN INFARCTION; BRAIN SIZE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROGNOSIS; WHITE MATTER; COMORBIDITY; DIAGNOSTIC IMAGING; FRANCE; LEUKOARAIOSIS; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN INFARCTION; COMORBIDITY; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; MALE; STROKE;

EID: 84988592626     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.116.014695     Document Type: Article

References (15)

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689-701. doi: 10.1016/S1474-4422(10)70104-6.
2. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-Analysis. BMJ. 2010;341:c3666.
3. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222. doi: 10.1056/NEJMoa022066.
4. 3C Study Group. Vascular factors and risk of dementia: design of the three-city study and baseline characteristics of the study population. Neuroepidemiology. 2003;22:316-325
5. Maillard P, Delcroix N, Crivello F, Dufouil C, Gicquel S, Joliot M, et al. An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases. Neuroradiology. 2008;50:31-42. doi: 10.1007/s00234-007-0312-3.
6. Zhu YC, Dufouil C, Mazoyer B, Soumare A, Ricolfi F, Tzourio C, et al. Frequency and location of dilated Virchow-Robin spaces in elderly people: a population-based 3D MR imaging study. AJNR Am J Neuroradiol. 2011;32:709-713. doi: 10.3174/ajnr.A2366.
7. Debette S, Beiser A, DeCarli C, Au R, Himali JJ, Kelly-Hayes M, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke. 2010;41:600-606. doi: 10.1161/STROKEAHA.109.570044.
8. Kuller LH, Longstreth WT Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr; Cardiovascular Health Study Collaborative Research Group. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke. 2004;35:1821-1825. doi: 10.1161/01. STR.0000132193.35955.69.
9. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM; Rotterdam Scan Study. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003;34:1126-1129. doi: 10.1161/01. STR.0000068408.82115.D2.
10. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal PJ, Oudkerk M, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol. 2004;61:1531-1534. doi: 10.1001/archneur.61.10.1531.
11. O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology. 2002;59:321-326.
12. Kuller LH, Lopez OL, Newman A, Beauchamp NJ, Burke G, Dulberg C, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology. 2003;22:13-22. doi: 67109.
13. Grimmer T, Faust M, Auer F, Alexopoulos P, Förstl H, Henriksen G, et al. White matter hyperintensities predict amyloid increase in Alzheimer's disease. Neurobiol Aging. 2012;33:2766-2773. doi: 10.1016/j.neurobiolaging.2012.01.016.
14. Kaffashian S, Tzourio C, Soumare A, Dufouil C, Zhu Y, Crivello F, et al. Plasma β-Amyloid and MRI markers of cerebral small vessel disease: Three-City Dijon study. Neurology. 2014;83:2038-2045. doi: 10.1212/WNL.0000000000001038.
15. Yoshita M, Fletcher E, Harvey D, Ortega M, Martinez O, Mungas DM, et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology. 2006;67:2192-2198. doi: 10.1212/01. wnl.0000249119.95747.1f.